Longevity Biomedical (Longevity Biomedical) ROE % Adjusted to Book Value : 0.00% (As of . 20)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical ROE % Adjusted to Book Value?

Longevity Biomedical's ROE % for the quarter that ended in . 20 was 0.00%. Longevity Biomedical's PB Ratio for the quarter that ended in . 20 was N/A. Longevity Biomedical's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

Longevity Biomedical ROE % Adjusted to Book Value Historical Data

The historical data trend for Longevity Biomedical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical ROE % Adjusted to Book Value Chart

Longevity Biomedical Annual Data

Trend

ROE % Adjusted to Book Value

Longevity Biomedical Semi-Annual Data

ROE % Adjusted to Book Value

Competitive Comparison of Longevity Biomedical's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Longevity Biomedical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's ROE % Adjusted to Book Value falls into.

Longevity Biomedical ROE % Adjusted to Book Value Calculation

Longevity Biomedical's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Longevity Biomedical's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Longevity Biomedical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines